Filing Details
- Accession Number:
- 0000950157-18-000023
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-01-02 13:39:01
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-01-02 13:39:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1600132 | Bellerophon Therapeutics Inc. | BLPH | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1505451 | Linde North America, Inc. | 200 Somerset Corporate Boulevard Bridgewater NJ 08807 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-11-29 | 1,920,000 | $0.00 | 5,271,796 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-09-29 | 1,721,992 | $0.00 | 5,271,796 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2016-11-29 | 1,920,000 | $0.00 | 1,920,000 | $0.80 |
| Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2017-09-29 | 1,721,992 | $0.00 | 1,721,992 | $1.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,920,000 | 2021-11-29 | No | 5 | P | Direct | |
| 1,721,992 | 2022-09-29 | No | 5 | P | Direct |
Footnotes
- The reported securities are included within Units purchased by the reporting person for $0.70 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
- The reported securities are included within Units purchased by the reporting person for $1.205 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
- The warrants to purchase shares of common stock are currently not exercisable by Linde North America, Inc. due to the exercise limitations of the warrants.
- The warrants to purchase shares of common stock are currently not exercisable by Linde North America, Inc. due to the exercise limitations of the warrants.
Billionaire Hedge Funds
